alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.1(b)




THIS CONVERTIBLE PROMISSORY NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR UNDER ANY SECURITIES LAWS OF ANY STATE. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER SUCH ACT OR ANY SUCH LAW.
   First China Pharmaceutical Group, Inc.
  January 21, 2011
  AMENDMENT TO THE CONVERTIBLE PROMISSORY NOTE DATED OCTOBER 3, 2010
  Caladonia Partners LLC(Holder) hereby extends the total funds available to First China Pharmaceutical Group, Inc, provided by the Convertible Promissory Note granted on October 3, 2010, to five hundred thousand dollars ($500,000.00).  This extension is provided on the same terms and conditions as documented in the Convertible Promissory Note granted on October 3, 2010 (see attached).
  IN WITNESS WHEREOF, the Company has caused this extension to the Convertible Promissory Note of October 3, 2010, to be signed in its name as of the date first above written.
   
 First China Pharmaceutical Group, Inc.By:
/s/ Zhen Jiang WangName:
Zhen Jiang WangTitle:
Chairman & Chief Executive Officer
  
 
 
 Agreed and Accepted.
  HOLDERCaledonia Partners LLC
    By:
/s/ R. SmithName:
R. SmithTitle:
Secretary
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

# ACTION:

Announcement of meeting. 

# SUMMARY:

This notice announces the 12th meeting of the American Health Information Community Personalized Healthcare Workgroup in accordance with the Federal Advisory Committee Act (Pub. L. 92-463, 5 U.S.C., App.)

# DATES:

February 14, 2008, from 1 p.m. to 3 p.m. [Eastern Time].

# ADDRESSES:

Mary C. Switzer Building (330 C Street, SW., Washington, DC 20201), Conference Room 4090. Please bring photo ID for entry to a Federal building.

# FOR FURTHER INFORMATION CONTACT:

*http://www.hhs.gov/​healthit/​ahic/​healthcare/​.*

# SUPPLEMENTARY INFORMATION:

The Workgroup will discuss possible common data standards to incorporate interoperable, clinically useful genetic/genomic information and analytical tools into Electronic Health Records (EHRs) to support clinical decision-making for the clinician and consumer.

                    The meeting will be available via Web cast. For additional information, go to:                     *http://www.hhs.gov/​healthit/​ahic/​healthcare/​phc_​instruct.html.*

Dated: January 17, 2008.

Judith Sparrow,

Director, American Health Information Community, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology.

[FR Doc. 08-364  Filed 1-28-08; 8:45 am]

BILLING CODE 4150-45-M
Advisory Board on Radiation and Worker Health

January 8, 2003

SUMMARY

of

CLOSED SESSION

Agenda:

9:45 a.m. Call to Order - Closed Session Dr. Paul Ziemer

9:50 a.m. Discussion of Proposed Independent Government Cost Estimate

for a Contract

Attendees:

Board Members:

Paul L. Ziemer, Ph.D., Chair

Larry J. Ellio~ Executive Secretary

Henry A. Anderson, M.D., Member

Antonio Andrade, Ph.D., Member

Roy L. DeHart, M.D., M.P.H., Member

Richard L. Espinosa, Member

Michael H. Gibson, Member

Mark A. Griffon, Member

James M. Melius, M.D., Dr.P.H., Member

Robert W. Presley, Member

Genevieve S. Roessler, Ph.D., Member

NIOSH Staff"

Jim Neton, David Naimon, Liz Homoki- Titus, Martha DiMuzio, Con Homer

Ray s. ~ Court Recorder

SUMMARY /MINUTES

Dr. Ziemer called to order the Advisory Board on Radiation and Worker Health

(ABRWH) in closed session on January 8, 2003 at 9:45 a.m. IThe purpose of the closed

meeting was to develop the Independent Government Cost Estimate for a contract to

provide technical support to the ABR WH review of completed dose reconstructions.

I The Board completed its public business ahead of schedule, and publicly

announced at the conclusion of its public business that the closed session would begin 15

minutes ahead of its scheduled start time of 10:00 a.m.
Dr. Ziemer noted that Ms. Wanda Munn and Mr. Leon Owens were not available to

attend and could not be connected via conference call due to telephone line security

Issues.

General topics discussed:

. Closed session procedures.

. Independent Government Cost Estimate.

. Member of Board to be appointed to the Technical Review Panel for this

procurement.

Dr. Paul Ziemer adjourned the closed session of the ABR WH meeting at 11: 18 a.m. with

no further business being conducted by the ABR WH.

2
<PAGE>   1

                                                                    EXHIBIT 23.2

                         INDEPENDENT AUDITORS' CONSENT

The Board of Directors
National Auto Finance Company, Inc.:

We consent to incorporation by reference in the registration statement (No.
333-23649) on Form S-8 of National Auto Finance Company, Inc. and subsidiaries
of our report dated April 15, 1998, relating to the consolidated balance sheet
of National Auto Finance Company, Inc. and subsidiaries as of December 31, 1997,
and the related consolidated statements of operations, stockholders' equity and
cash flows for each of the years in the two-year period ended December 31, 1997,
which report appears in the December 31, 1998, annual report on Form 10-K of
National Auto Finance Company, Inc. and subsidiaries.

Our report dated April 15, 1998 contains an explanatory paragraph that states
that the Company has suffered losses from operations, experienced an Insurance
Agreement Event of Default with respect to its securitizations, and at December
31, 1997 was in violation of various covenants related to its borrowings, which
raise substantial doubt about its ability to continue as a going concern. The
consolidated financial statements do not include any adjustments that might
result from the outcome of that uncertainty.

Our report also refers to the adoption of the provisions of the Financial
Accounting Standards Board's Statement of Financial Accounting Standards No. 125
"Accounting for Transfers and Servicing of Financial Assets and Extinguishments
of Liabilities," in 1997.

                                                   KPMG LLP

Fort Lauderdale, Florida
May 11, 1999
Bounding Stable Metal Tritide (

Exposures at the Mound Labora

James W. Neton, Ph.D., CHP

Associate Director for Science

National Institute for Occupational Safety and Health

Division of Compensation Analysis and Support

September 2012

Denver, CO
Stable Metal Tritide (SMT)

Overview

 Most forms of tritium (e.g., HTO, OBT) are

relatively soluble in the body

 SMTs are tritium‐metal compounds that are

chemically unreactive (i.e., do not dissociate

easily)

 The most unreactive forms (e.g., HfT) have ve

long biological clearance times in the body

• Are considered ICRP solubility type S

 Urinalysis is ineffective for quantifying intake

SMTs in the presence of other more soluble

forms
SMT Overview—cont.

 Tritium research occurred at Mound in the 

tritium Complex (SRTC)

 Operations started in the 1960s and continu

beyond the 1990s

 Workers could have handled and been expo

both soluble and insoluble forms of tritium

• All workers in SRTC on a routine tritium bioassa

• Workers who directly handled SMTs were relati

• NIOSH has established identity of these worker

 Method needed to evaluate SMT exposures 

support workers
Approach to SMT Exposure Evalu

Support Staff

 Routine tritium contamination surveys tak

the SRTC

 NIOSH collected and reviewed survey data 

>10,000 documents

• Resulted in >69,000 smears taken in 4 rooms b

1968 and 1989

• Probability distributions of the contamination 

the rooms were established
Approach to SMT Exposure

Evaluation

Support Staff—cont.

 Using the 95th percentile values and a claim

favorable resuspension factor (5E‐05/m), t

intake for a support worker can be calculat

 Intakes assume that worker is exposed to t

value for the entire work year

• Also assumes that the intake is to SMTs

 Dose calculation:

• Use urine data for estimating systemic organs • Calculate lung dose using both SMT resuspens

model and urinary excretion values
Doses to Workers

 Applying the bounding approach to suppo

workers results in relatively small lung dos

 Values vary depending on specific exposur

scenario

• Annual lung doses using the 95th percentile

contamination values are in the several mrem 

 Methodology demonstrates that potential 

to support workers (i.e. those that did notdirectly handle SMTs) are low and can bebounded
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 23-6968

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v.

VICTOR LEBRON, a/k/a Victor Labron,

Defendant - Appellant.

Appeal from the United States District Court for the Western District of Virginia, at Big 

Stone Gap. James P. Jones, Senior District Judge. (2:18-cr-00008-JPJ-PMS-2; 2:22-cv81510-JPJ)

Submitted: December 19, 2023 Decided: December 27, 2023

Before HARRIS, QUATTLEBAUM, and BENJAMIN, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Victor Lebron, Appellant Pro Se. Steven Randall Ramseyer, Assistant United States 

Attorney, OFFICE OF THE UNITED STATES ATTORNEY, Abingdon, Virginia, for 

Appellee. 

Unpublished opinions are not binding precedent in this circuit.

USCA4 Appeal: 23-6968 Doc: 6 Filed: 12/27/2023 Pg: 1 of 2
2

PER CURIAM:

Victor Lebron seeks to appeal the district court’s order denying relief on his 28 

U.S.C. § 2255 motion. The order is not appealable unless a circuit justice or judge issues 

a certificate of appealability. See 28 U.S.C. § 2253(c)(1)(B). A certificate of appealability 

will not issue absent “a substantial showing of the denial of a constitutional right.” 28 

U.S.C. § 2253(c)(2). When the district court denies relief on the merits, a prisoner satisfies 

this standard by demonstrating that reasonable jurists could find the district court’s 

assessment of the constitutional claims debatable or wrong. See Buck v. Davis, 580 U.S. 

100, 115-17 (2017). When the district court denies relief on procedural grounds, the 

prisoner must demonstrate both that the dispositive procedural ruling is debatable and that 

the motion states a debatable claim of the denial of a constitutional right. Gonzalez v. 

Thaler, 565 U.S. 134, 140-41 (2012) (citing Slack v. McDaniel, 529 U.S. 473, 484 (2000)). 

We have independently reviewed the record and conclude that Lebron has not made 

the requisite showing. Accordingly, we deny a certificate of appealability and dismiss the 

appeal. We dispense with oral argument because the facts and legal contentions are 

adequately presented in the materials before this court and argument would not aid the 

decisional process. 

DISMISSED

USCA4 Appeal: 23-6968 Doc: 6 Filed: 12/27/2023 Pg: 2 of 2
[Federal Register Volume 72, Number 41 (Friday, March 2, 2007)]
[Notices]
[Page 9536]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-948]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institute for Occupational Safety and Health; 
Designation of a Class of Employees for Addition to the Special 
Exposure Cohort

AGENCY: National Institute for Occupational Safety and Health (NIOSH), 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) gives notice 
of a decision to designate a class of employees at General Atomics in 
La Jolla, California, as an addition to the Special Exposure Cohort 
(SEC) under the Energy Employees Occupational Illness Compensation 
Program Act of 2000. On February 16, 2007, the Secretary of HHS 
designated the following class of employees as an addition to the SEC:

Atomic Weapons Employer (AWE) employees who were monitored or should 
have been monitored for exposure to ionizing radiation while working 
at the General Atomics facility in La Jolla, California at the 
following locations: Science Laboratories A, B, and C (Building 2); 
Experimental Building (Building 9); Maintenance (Building 10); 
Service Building (Building 11); Buildings 21 and 22; Hot Cell 
Facility (Building 23); Waste Yard (Buildings 25 and 26); 
Experimental Area (Buildings 27 and 27-1); LINAC Complex (Building 
30); HTGR-TCF (Building 31); Fusion Building (Building 33); Fusion 
Doublet III (Building 34); SV-A (Building 37); SV-B (Building 39); 
and SV-D (no building number) for a number of work days aggregating 
at least 250 work days from January 1, 1960, through December 31, 
1969, or in combination with work days within the parameters 
established for one or more other classes of employees in the 
Special Exposure Cohort.

    This designation will become effective on March 18, 2007, unless 
Congress provides otherwise prior to the effective date. After this 
effective date, HHS will publish a notice in the Federal Register 
reporting the addition of this class to the SEC or the result of any 
provision by Congress regarding the decision by HHS to add the class to 
the SEC.

FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of 
Compensation Analysis and Support, National Institute for Occupational 
Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46, Cincinnati, 
OH 45226, Telephone 513-533-6800 (this is not a toll-free number). 
Information requests can also be submitted by e-mail to <a href="/cdn-cgi/l/email-protection#357a767466757671761b727a63"><span class="__cf_email__" data-cfemail="7a35393b293a393e39543d352c">[email protected]</span></a>.

    Dated: February 23, 2007.
John Howard,
Director, National Institute for Occupational Safety and Health.
[FR Doc. 07-948 Filed 3-1-07; 8:45 am]
BILLING CODE 4160-17-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Wolfe Creek Mining, Inc. (the
"Company") on Form 10-Q for the period ending June 30, 2008 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Kristen
Paul, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
4th day of August, 2008.


/s/ Kristen Paul
------------------------------
Chief Financial Officer
|  |  |  |
|--|--|--|
|  |

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K/ACURRENT REPORTPursuant to Section 13 or 15(d) of theSecurities Exchange Act of 1934Date of Report (Date of earliest event reported): April 25, 2022 (December 13, 2021)L3HARRIS TECHNOLOGIES, INC.(Exact name of registrant as specified in its charter)Delaware1-386334-0276860(State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification No.)1025 West NASA BoulevardMelbourne,Florida 32919(Address of principal executive offices)(Zip Code)Registrant’s telephone number, including area code: (321) 727-9100No change(Former name or former address, if changed since last report)Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))Securities registered pursuant to Section 12(b) of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon Stock, par value $1.00 per shareLHXNew York Stock ExchangeIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company☐If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.       ☐This Form 8-K/A (Amendment No. 1) is being filed by L3Harris Technologies, Inc. ("L3Harris" or the "Company")to update the disclosure in the Company's Current Report on Form 8-K filed with the Securities and ExchangeCommission on December 13, 2021 ("Original Report").Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) As previously reported in the Original Report, Harry B. Harris, Jr. was appointed to the Board of Directors (the "Board") of  the Company effective December 9, 2021. On April 22, 2022, on the recommendation of the Nominating and Governance Committee of the Board, the Board appointed Harry B. Harris, Jr. to the Innovation and Cyber Committee of the Board, effective on that date. 1SIGNATURE     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.L3HARRIS TECHNOLOGIES, INC. By:/s/ Scott T. MikuenName:Scott T. MikuenDate: April 25, 2022Title:Senior Vice President, General Counsel and Secretary2
Exhibit 99.01

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of Eventemp Corporation (the
"Company") on Form 10-KSB for the period ended December 31, 2002, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      The  Report  fully  complies  with the  requirements  of
                  Section  13(a) or 15(d) of the  Securities Exchange Act of
                  1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.

                                             /s/ Keith D. Spickelmier
                                             Keith D. Spickelmier,
Date: April 7, 2003                          President & Chief Executive Officer


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of Eventemp Corporation (the
"Company") on Form 10-KSB for the period ended December 31, 2002, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      The  Report  fully  complies  with the  requirements  of
                  Section  13(a) or 15(d) of the  Securities Exchange Act of
                  1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.

                                          /s/ Keith D. Spickelmier
                                          Keith D. Spickelmier,
Date: April 7, 2003                       Treasurer & Chief Financial Officer